PAPER Wong CC, Wallhagen MI

Family Caregivers of Individuals with Frontotemporal Dementia: Examining the Relationship Between Coping and Caregiver Physical and Mental Health.

J Gerontol Nurs. 2013 Sep 4;:1-11. PubMed: 24015887

PAPER Paulos JP, Massano J

Clinical, Genetic and Neuropathological Features of Frontotemporal Dementia: An Update and Guide.

Acta Med Port. 2013 Jul-Aug;26(4):392-401. PubMed: 24016649

PAPER Butcher NJ, Kiehl TR, Hazrati LN, Chow EW, Rogaeva E, Lang AE, Bassett AS

Association Between Early-Onset Parkinson Disease and 22q11.2 Deletion Syndrome: Identification of a Novel Genetic Form of Parkinson Disease and Its Clinical Implications.

JAMA Neurol. 2013 Nov 1;70(11):1359-66. PubMed: 24018986

PAPER Pla P, Orvoen S, Benstaali C, Dodier S, Gardier AM, David DJ, Humbert S, Saudou F

Huntingtin acts non cell-autonomously on hippocampal neurogenesis and controls anxiety-related behaviors in adult mouse.

PLoS One. 2013;8(9):e73902. PubMed: 24019939

PAPER Riley J, Glass J, Feldman EL, Polak M, Bordeau J, Federici T, Johe K, Boulis NM

Intraspinal Stem Cell Transplantation in ALS: A Phase I Trial, Cervical Microinjection and Final Surgical Safety Outcomes.

Neurosurgery. 2013 Sep 5; PubMed: 24018694

PAPER Boyd JD, Lee-Armandt JP, Feiler MS, Zauur N, Liu M, Kraemer B, Concannon JB, Ebata A, Wolozin B, Glicksman MA

A High-Content Screen Identifies Novel Compounds That Inhibit Stress-Induced TDP-43 Cellular Aggregation and Associated Cytotoxicity.

J Biomol Screen. 2013 Sep 9; PubMed: 24019256

PAPER Rossi G, Bastone A, Piccoli E, Morbin M, Mazzoleni G, Fugnanesi V, Beeg M, Del Favero E, Cantù L, Motta S, Salsano E, Pareyson D, Erbetta A, Elia AE, Del Sorbo F, Silani V, Morelli C, Salmona M, Tagliavini F

Different mutations at V363 MAPT codon are associated with atypical clinical phenotypes and show unusual structural and functional features.

Neurobiol Aging. 2014 Feb;35(2):408-17. Epub 2013 Sep 7 PubMed: 24018212

PAPER Ojha B, Liu H, Dutta S, Rao PP, Wojcikiewicz EP, Du D

Poly(4-styrenesulfonate) as an Inhibitor of Aβ40 Amyloid Fibril Formation.

J Phys Chem B. 2013 Nov 14;117(45):13975-84. PubMed: 24015976

PAPER Stefulj J, Peric M, Malnar M, Kosicek M, Schweinzer C, Zivkovic J, Scholler M, Panzenboeck U, Hecimovic S

Pharmacological Activation of LXRs Decreases Amyloid-β Levels in Niemann-Pick Type C Model Cells.

Curr Pharm Biotechnol. 2013 Jul;14(6):582-93. PubMed: 24016269

PAPER Chen Y, Behnisch T

The role of γ-secretase in hippocampal synaptic transmission and activity-dependent synaptic plasticity.

Neurosci Lett. 2013 Oct 25;554:16-21. PubMed: 24016412

PAPER Zhu YP, Chen MF, Shen BH

[A prevalence study on mild cognitive impairment among elderly populations in Zhejiang province].

Zhonghua Liu Xing Bing Xue Za Zhi. 2013 May;34(5):475-7. PubMed: 24016438

PAPER Chételat G, Fouquet M

Neuroimaging biomarkers for Alzheimer's disease in asymptomatic APOE4 carriers.

Rev Neurol (Paris). 2013 Oct;169(10):729-36. PubMed: 24016463

PAPER Mills SM, Mallmann J, Santacruz AM, Fuqua A, Carril M, Aisen PS, Althage MC, Belyew S, Benzinger TL, Brooks WS, Buckles VD, Cairns NJ, Clifford D, Danek A, Fagan AM, Farlow M, Fox N, Ghetti B, Goate AM, Heinrichs D, Hornbeck R, Jack C, Jucker M, Klunk WE, Marcus DS, Martins RN, Masters CM, Mayeux R, McDade E, Morris JC, Oliver A, Ringman JM, Rossor MN, Salloway S, Schofield PR, Snider J, Snyder P, Sperling RA, Stewart C, Thomas RG, Xiong C, Bateman RJ

Preclinical trials in autosomal dominant AD: Implementation of the DIAN-TU trial.

Rev Neurol (Paris). 2013 Oct;169(10):737-43. PubMed: 24016464

PAPER Dorothée G, Sarazin M, Aucouturier P

Disease-specific adaptive immune biomarkers in Alzheimer's disease and related pathologies.

Rev Neurol (Paris). 2013 Oct;169(10):715-8. PubMed: 24016465

PAPER Engelborghs S

Clinical indications for analysis of Alzheimer's disease CSF biomarkers.

Rev Neurol (Paris). 2013 Oct;169(10):709-14. PubMed: 24016466